Category: Case Study
Tailored Approach Supports Bladder Cancer Breakthrough Since 2020, Catalyst Oncology has supported an emerging biotech’s oncology program. Focused on developing the Read Now
Accelerating a Global, FIH ADC Therapy Trial for Lung Cancer An innovative biotech was developing a next-generation antibody-drug conjugate (ADC) for the treatment of non-small Read Now 